Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions
about
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signalsSpecific tetraspanin functionsTargeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceuticalTetraspanins and Transmembrane Adaptor Proteins As Plasma Membrane Organizers-Mast Cell CaseFunction and Dynamics of Tetraspanins during Antigen Recognition and Immunological Synapse FormationTetraspanins as therapeutic targets in hematological malignancy: a concise reviewTetraspanin functions and associated microdomainsTHOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivoCharacterization of mice lacking the tetraspanin superfamily member CD151AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLScreening of genes of proteins interacting with p7 protein of hepatitis C virus from human liver cDNA library by yeast two-hybrid systemThe tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityA conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells.The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus.Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.Anti-CD37 antibodies for chronic lymphocytic leukemia.The absence of Tssc6, a member of the tetraspanin superfamily, does not affect lymphoid development but enhances in vitro T-cell proliferative responses.Tetraspanin CD37 protects against the development of B cell lymphomaAssessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC.Lateral organization of membrane proteins: tetraspanins spin their web.SMIP-016 in action: CD37 as a death receptorMucosal tolerance to E-selectin and response to systemic inflammation.Tetraspanin microdomains in immune cell signalling and malignant disease.Potential immunosuppressive effects of Escherichia coli O157:H7 experimental infection on the bovine host.Progress in multiple sclerosis genetics.Targeting of tetraspanin proteins--potential benefits and strategiesFunctional implications of tetraspanin proteins in cancer biology.Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal functionA phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemiaTetraspanins in cellular immunity.Tetraspanins in the humoral immune response.New targets for antibody therapy of pediatric B cell lymphomas.Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.Dectin-1-CD37 association regulates IL-6 expression during Toxoplasma gondii infection.Differential tissue expression of epitopes of the tetraspanin CD151 recognised by monoclonal antibodies.
P2860
Q24336378-AB9C89C4-4227-43C2-8BC8-C2A43DC9C965Q24652356-0C676F75-DF8C-48D0-B8A7-BBF2083F01B9Q24681992-EB655A3D-DFB1-4F10-8838-D14F1F294795Q26744486-87ECD8C6-AF7F-4562-9F5B-AE0B0B7F7D39Q26770383-4F14BFEB-CE0B-44BC-9DCB-E09027BE4A7FQ27002353-06118483-230A-4A76-80B2-C7F838DF82F9Q28284176-1D25AF94-79FE-46EB-84E2-7ACF9DC225C2Q28509792-A30D8337-F17E-4B8F-A92C-5838E81B8363Q28587010-D42BAAE1-ABF9-4275-8048-226C91AC7B62Q30403563-84187C6F-D71D-474A-8447-C123F6BDD8C4Q33221544-5893EE5D-2985-4338-B56D-F96CA03C34F5Q33417649-4ABAA862-3ECF-4566-A682-59F5F2B0D052Q33778199-B42D0828-BCC8-4DE7-9C09-5B1E384C605AQ33816306-6B650122-1F69-4487-B27F-ED4CF0620ADEQ33925311-73FFCDF5-58E6-41D0-8F42-9D50DDBF0D92Q34122286-E84237DB-B174-42D2-B677-1E7C0500CC20Q34311595-1AFBDFDC-344A-4002-8E0D-13D2FB73918AQ34326036-33C4095C-C7A2-4C78-9B30-0FAF684474A3Q34353684-38F5138E-0D1C-4F95-952D-89A60DABF11FQ34405641-E9E7C85C-E5F5-44E9-BF65-1E38BE19CCF3Q34441877-DB9FD57E-C8D4-4EEB-91AE-27200B368920Q34509755-CA4D0CDF-1CD8-4D28-B5C0-4891FE5FEFA7Q34543066-19C76AF8-57F9-41E8-9E9F-5F6EDFE938E4Q34906225-65B8D4FF-9652-47C9-8B74-B7AFC65D96EAQ34979935-2B098E75-1770-4A06-9357-0363D5F8240AQ35186444-7186B568-A977-490D-A0FC-1E12012D973DQ35754404-616DC300-3A42-40B4-B131-A102E9FFC016Q35923947-9ECBDD35-D94B-4B0F-8EB4-CDD3D90D60FAQ36230692-24CC5BBB-BDA1-4EB8-B1FA-9B75E51997D2Q36382352-068C4C24-77AD-4E51-8DCD-FD74204E3708Q36533706-C3D02122-94F8-4AAE-98E9-FB059B53D8CBQ36922587-B6A86345-F463-4825-8B70-EA20B4201D82Q37099908-99EF890D-BD80-4D38-A376-04890FBE8E9DQ37609420-9D2B6B24-58CE-4DA4-A7CA-A52C5E4A105DQ37856388-A7E059D9-8DAC-4906-A200-BBA5B1F89AA8Q37856389-8398EA2B-E437-46F5-A9FA-6C70B23B5808Q38242984-4FBD74DD-B340-49C5-A84A-790F84EC0A54Q38588362-4B0E49B2-57BB-4199-96A6-9AF6EA23B35EQ38990827-224EBB04-C47D-43DE-B181-9BB4773BB671Q40769402-E388BA18-5ED7-4CF6-89C8-8DD5345A72C6
P2860
Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions
description
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/08/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/08/01)
@nl
наукова стаття, опублікована в серпні 2000
@uk
مقالة علمية (نشرت في أغسطس 2000)
@ar
name
Targeted inactivation of the t ...... timal costimulatory conditions
@ast
Targeted inactivation of the t ...... timal costimulatory conditions
@en
Targeted inactivation of the t ...... timal costimulatory conditions
@nl
type
label
Targeted inactivation of the t ...... timal costimulatory conditions
@ast
Targeted inactivation of the t ...... timal costimulatory conditions
@en
Targeted inactivation of the t ...... timal costimulatory conditions
@nl
prefLabel
Targeted inactivation of the t ...... timal costimulatory conditions
@ast
Targeted inactivation of the t ...... timal costimulatory conditions
@en
Targeted inactivation of the t ...... timal costimulatory conditions
@nl
P2093
P2860
P3181
P1476
Targeted inactivation of the t ...... timal costimulatory conditions
@en
P2093
A. F. Ochsenbein
K. P. Knobeloch
M. D. Wright
O. Liesenfeld
R. M. Zinkernagel
Z. Orinska
P2860
P304
P3181
P356
10.1128/MCB.20.15.5363-5369.2000
P407
P577
2000-08-01T00:00:00Z